Seroepidemiological studies of Chlamydia pneumoniae infections in 1-36 months old children with respiratory tract infections and other diseases in Poland

• Autorzy: Podsiadly E , Fracka B. , Szmigielska A. , Tylewska-Wierzbanowska S.
• Języki publikacji: EN

Abstrakty

EN

Presence of specific IgM, IgG and IgA antibodies against Chlamydia pneumoniae was evaluated in children aged 1 week to 36 months to investigate the role of C. pneumoniae in respiratory infections and other diseases. Serum samples were obtained from 150 hospitalized children, including 123 children presenting the clinical symptoms of various respiratory tract infections, two children with acute diarrhoea, two children with meningitis, 14 children with urinary tract infection, and 9 children with non-infectious diseases. Levels of specific C. pneumoniae IgM, IgG and IgA serum antibodies were measured by enzyme-linked immunoassay (ELISA). C. pneumoniae IgM antibodies were detected in 16 (13.0 %) of 123 children with respiratory tract infections. Specific IgG antibodies were found in sera of 11 children under 12 months old. Among 27 children without symptoms of a respiratory tract disease, specific C. pneumoniae IgM were found in two (7.4%) children, including one child with meningitis and another child with urinary tract infection. Specific IgA antibodies were not found in any tested child. All cases of C. pneumoniae infections were identified within two calendar years out of eight that were analyzed, i.e. in 1997 and 2000. The incidence of C. pneumoniae infections varied seasonally, with most children infected in autumn. C. pneumoniae IgM antibodies were detected more often in girls (17.9%) then in boys (7.2%). C. pneumoniae infections occur among small children in central Poland. The results of this study indicate that C. pneumoniae may play a role in the etiology of respiratory tract infections in infants and young children.

Słowa kluczowe

EN

Chlamydia pneumoniae; disease; infection; respiratory tract; human pathogen; Poland; child; antibody

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2005
• Tom: 54
• Numer: 3
• Opis fizyczny: p.215-219,fig.,ref.

Twórcy

autor

Podsiadly E

• National Institute of Hygiene, Chocimska 24, 00-791 Warsaw, Poland

autor

Fracka B.

autor

Szmigielska A.

autor

Tylewska-Wierzbanowska S.

Bibliografia

• Baer G., G. Engelcke, M. Abele-Horn, U.B. Schaad and U. Heininger. 2003. Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalized children and adolescents. Eur. J. Clin. Microbiol. Infect. Dis. 22: 742-745.
• Block S., J. Hedrick, M.R. Hammerschlag, G.H. Cassel and J.C. Craft. 1995. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of claritromycin vs. erythromycin ethylsuccinate. Pediatr. Infec. Dis. J. 14: 471-477.
• Chirgwin K., P.M. Roblin, M. Gelling, M.R. Hammerschlag and J. Schacher. 1991. Infection with Chlamydia pneumoniae in Brooklyn. J. Infect. Dis. 163: 757-761.
• Dowell S.R, R.W. Peeling, J. Boman, G.M. Carlone, B.S. Fields, J. Guwner, M.R. Hammerschlag, L.A. Jackson, C.C. Kuo, M. Maass, T.O. Messmer, D.F. Talkington, M.L. Tondella and S.R. Zaki. 2001. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin. Infect. Dis. 33: 492-503.
• Ekman M. 1993. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae during an epidemic in Finland. Eur J. Clin. Microbiol. Infec. Dis. 12: 756-760
• Emre U., P.M. Roblin and M. Gelling. 1994. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch. Pediatr. Adolesc. Med. 148: 727-729.
• Forgie I.M., K.P. O'Neill, N. Lloyd-Evans, M. Leinonen, H. Campbell and H.C. Whittle. 1991. Etiology of acute lower respiratory tract infections in Gambian children: II. Acute lower respiratory tract infection in children ages one to nine years presenting at hospital. Pediatr Infect. Dis. J. 10: 42-47.
• Grayston J.T. 2000. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J. Infect. Dis. 181 (suppl 3): S402-411.
• Gutierrez J., J. Mendoza, F. Fernandez, J. Linares-Palomino, M.J. Soto and M.C. Maroto. 2002. ELISA test to detect Chlamydophilapneumoniae IgG. J. Basic Microbiol. 42: 13-18.
• Hammerschlag M.R. 2003. Pneumonia due to Chlamydia pneumoniae in children: epidemiology, diagnosis, and treatment. Pediatr. Pulmonal. 36: 384-390.
• Heiskanen-Kosma T, M. Korppi, A. Laurila, C. Jokinen, M. Kleemola and P. Saikku. 1999. Chlamydia pneumoniae is an important cause of community-acquired pneumonia in school-aged children: serological results of a prospective, population-based study. Scan. J. Infect. Dis. 31: 255-259.
• Heiskanen-Kosma T., M. Korppi, C. Jokinen, S. Kurki, L. Heiskanen, H. Juvonen, S. Kallinen, M. Sten, A. Tarkiainen, R.R. Ronnberg, M. Kleemola, H. Makela and M. Leinonen. 1998. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr. Infec. Dis. J. 17: 986 -991.
• Herrmann B., M.A. Salih, B.E. Yousif, O. Abdelwahab and P.A. Mardh. 1994. Chlamydial etiology of acute lower respiratory tract infections in children in Sudan. Acta Paediatr. 83: 169-172.
• Hyman C.L., P.M. Roblin, CA. Gay dos, T.C. Qu inn, J. Schacher and M.R. Hamm er schlag. 1995. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin. Infect. Dis. 20: 1174-1178.
• Kishimoto H. 1990. Research into the comparison between healthy adults and those suffering from C. pneumoniae (TWAR) acute respiratory infection through serum based epidemiological examination. J. Inject. Dis. 64: 986-992.
• Kishimoto H. 1996. The foundation and clinical serum based diagnosis of Chlamydia pneumoniae. Sphere Seien. Cure 12: 2250-2256.
• Kuo C.C, L.A. Jackson and L.A. Campbell. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8: 451-461.
• Kutlin A., P.M. Roblin and M.R. Hammerschlag. 1998. Antibody response to Chlamydia pneumoniae infection in children with respiratory illness. J. Inject. Dis. 177: 720-724.
• Likitnukul S., P. Nunthapisud and N. Prapphal. 2003. Prevalence of Chlamydia pneumoniae infection in Thai children with community-acquired pneumonia. Pediatr. Infect. Dis. J. 22:749-750.
• Lin T.M., C.C. Kuo, W.J. Chen, F.J. Lin and H.L. Eng. 2004. Seroprevalence of Chlamydia pneumoniae infection in Taiwan. J. Infect. 48:91-95.
• Lund-Olsen I., A. Lundback, J. Gnarpe and H. Gnarpe. 1994. Prevalence of specific antibodies to Chlamydia pneumoniae in children with acute respiratory infections. Acta Paediatr. 83: 1143-1145.
• Numazaki K., T. Ikebe and S. Chiba. 1996. Detection of serum antibodies against Chlamydia pneumoniae by ELISA. FEMS Immunol. Med. Microbiol. 14: 179-183.
• Saikku P., P. Ruutu, M. Leinonen, J. Panelius, T.E. Tupasi and J.T. Grayston. 1988. Acute lower-respiratory-tract infection associated with chlamydial TWAR antibody in Filipino children. J. Infect. Dis. 158: 1095-1097.
• Schmidt S.M., C.E. Muller, B. Mahner and S.K. Wiersbitzky. 2002. Prevalence, rate of persistence and respiratory tract symptoms of Chlamydia pneumoniae infection in 1211 kindergarten and school age children. Pediatr. Infect. Dis. J. 21: 758-762.
• Tagle M., R. Kogan, P. Rojas, L. Rubilar, R. Vidal and E. Paya. 2000. Diagnosis of Chlamydia pneumoniae in community-acquired pneumonia in children in Chile. Acta Paediatr. 89: 650-653.
• Tuuminen T, S. Varjo, H. Ingman, T. Weber, J. Oksi and M. Viljanen. 2000. Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays. Clin. Diagn. Lab. Immunol. 7: 734-738.